Reduced neutralizing activity of post-SARS-CoV-2 vaccination serum against variants B.1.617.2, B.1.351, B.1.1.7+E484K and a sub-variant of C.37
暂无分享，去创建一个
H. van Bakel | D. Sather | V. Simon | L. Mulder | Z. Khan | F. Krammer | F. Amanat | P. Desai | A. Gonzalez-Reiche | E. Sordillo | R. Banu | L. Cao | Rachel Chernet | J. M. Carreño | K. Srivastava | G. Kleiner | D. Jurczyszak | H. Kawabata | C. Gleason | Gagandeep Singh | J. Tcheou | A. Raskin | D. Bielak | Russo | A. van de Guchte | E. Ferreri | D. Floda | A. Salimbangon | M. Saksena | J. Matthews | W. Mendez | L. Sominsky | H. Alshammary | A. Shin | A. Amoako | S. Fabre | K. Beach | Mahmoud H. Awawda | Carolina Bermúdez-González | Kayla Dr. Alberto E Paniz-Mondolfi | K. Srivastava | Giulio Kleiner